Robotic surgery for superior mesenteric artery syndrome (SMAS) using duodenal derotation with duodenoduodenostomy is safe and effective, according to Gram Research analysis of 33 patients. The procedure succeeded in 97% of cases with no deaths, and 90.6% of patients experienced significant pain relief, 81.3% stopped needing feeding tubes, and 84.4% regained lost weight within 2 years.
Researchers at a major medical center tested a new robotic surgery technique for superior mesenteric artery syndrome (SMAS), a rare condition where a blood vessel squeezes the small intestine. According to Gram Research analysis, 33 patients underwent this minimally invasive procedure, and results were encouraging: over 90% experienced significant pain relief, most stopped needing feeding tubes, and patients regained lost weight. The surgery took about 5.8 hours on average, and patients stayed in the hospital for about 8-9 days. While this is still a small study, it suggests robotic surgery might be a safer option for this serious condition than traditional open surgery.
Key Statistics
A 2026 case series of 33 patients found that robotic duodenal derotation with duodenoduodenostomy for superior mesenteric artery syndrome was successful in 32 patients (97%), with only one conversion to open surgery.
Among 32 patients who completed follow-up after robotic surgery for SMAS, 90.6% experienced significant pain relief, 81.3% no longer required supplemental nutrition, and 84.4% regained significant weight within 2 years.
A single-surgeon case series of 33 SMAS patients treated with robotic surgery reported an average operative time of 346.9 minutes, average hospital stay of 8.7 days, and only 6 postoperative complications (18%) with zero mortalities.
In a 2026 study of 33 patients undergoing robotic surgery for SMAS, 19 patients (58%) also had concurrent surgery for Median Arcuate Ligament Syndrome, demonstrating the versatility of the minimally invasive approach for multiple contributing conditions.
The Quick Take
- What they studied: Whether doctors can safely perform a specific robotic surgery technique to treat superior mesenteric artery syndrome (SMAS), a rare condition where a major blood vessel pinches the small intestine and prevents food from moving through properly.
- Who participated: 33 patients who had the robotic surgery between June 2023 and July 2025 at a single hospital. Most patients were severely malnourished and weak before surgery because their condition prevented them from eating normally.
- Key finding: The robotic surgery was performed safely with no deaths and only one case requiring conversion to traditional open surgery. Among the 32 patients who completed follow-up, 90.6% had significant pain relief, 81.3% no longer needed feeding tubes, and 84.4% regained significant weight.
- What it means for you: If you or a loved one has SMAS, this research suggests robotic surgery might be a safer, less invasive option than traditional open surgery. However, this is still early research from one hospital, so discuss all options with your doctor. Recovery takes about 1-2 weeks in the hospital.
The Research Details
This was a retrospective case series, meaning researchers looked back at medical records of 33 patients who had already undergone robotic surgery for SMAS between June 2023 and July 2025. One surgeon performed all the procedures at a single medical center. The researchers collected information about what happened before surgery (patient condition), during surgery (how long it took, any problems), and after surgery (complications, recovery, symptom improvement).
The specific procedure involved using a robot-assisted surgical system to carefully separate and reposition the small intestine (duodenum) and create a new connection between two parts of the intestine (duodenoduodenostomy). This bypasses the area where the blood vessel was squeezing the intestine. Nineteen patients also had surgery to release a ligament (Median Arcuate Ligament) that was contributing to their symptoms.
The researchers followed patients for varying lengths of time, from about 4 weeks to 2 years after surgery, to see how well they recovered and whether their symptoms improved.
This research matters because SMAS is a serious, rare condition that can be life-threatening if not treated properly. Previous studies showed that traditional open surgery (duodenojejunostomy) only helped about one-third of patients. This new robotic approach appears to work better, but it’s important to test whether it can be done safely with the robot-assisted system, which uses smaller incisions and may cause less trauma to the body. This study is the first to describe this specific robotic technique for SMAS.
This study has some important strengths and limitations. Strengths: All surgery was performed by one experienced surgeon, which reduces variation in technique; detailed medical records were available; follow-up data was collected; and there were no deaths. Limitations: This is a small study from one hospital, so results may not apply everywhere; one patient was lost to follow-up; follow-up times varied widely (some patients only 4 weeks, others 2 years); and there’s no comparison group of patients who had traditional open surgery, so we can’t directly compare safety and effectiveness.
What the Results Show
The robotic surgery was performed successfully in 32 of 33 patients (97%). Only one patient required conversion to traditional open surgery during the procedure. The average surgery time was 346.9 minutes (about 5 hours and 47 minutes). Patients stayed in the hospital an average of 8.7 days.
After surgery, the vast majority of patients improved significantly. Among the 32 patients with follow-up data: 90.6% (29 patients) experienced significant pain relief, meaning their stomach pain either went away or became much better; 81.3% (26 patients) no longer needed supplemental nutrition (feeding tubes or special nutrition drinks); and 84.4% (27 patients) experienced significant weight regain, recovering the weight they had lost due to their condition.
There were 6 postoperative complications among the 33 patients (18%), which is relatively low given that these patients were severely malnourished and weak before surgery. There were no deaths. The complications were manageable and did not prevent patients from recovering.
Nineteen patients (58%) also underwent concurrent surgery to release the Median Arcuate Ligament (MALS), another condition that was contributing to their symptoms. These patients had similar good outcomes to those who had only the duodenal derotation procedure. The fact that the robotic approach could safely handle both procedures simultaneously suggests it’s a versatile technique for patients with multiple contributing problems.
This study’s results compare favorably to previous research. The Cleveland Clinic’s study of 18 patients using a different surgical technique (duodenojejunostomy) showed only 33% improvement at 3 years. Another study by Alvear et al reported 94.7% improvement with duodenal derotation alone, but 7 of those 19 patients (37%) later needed additional surgery. The current study shows 84-90% improvement with duodenal derotation plus duodenoduodenostomy, and importantly, this was achieved with minimally invasive robotic surgery rather than traditional open surgery, which typically means less pain, smaller scars, and faster recovery.
Several important limitations should be considered: First, this is a small study from one hospital with one surgeon, so results may not apply to other hospitals or surgeons. Second, follow-up time varied greatly—some patients were only followed for 4 weeks while others for 2 years, making it hard to know long-term outcomes. Third, one patient was lost to follow-up entirely. Fourth, there’s no comparison group of patients who had traditional open surgery, so we can’t directly prove the robotic approach is better. Fifth, SMAS is so rare that even 33 patients is a small number for drawing firm conclusions. Finally, this is a retrospective study looking back at medical records, which can miss information or have errors compared to a prospective study that follows patients forward in time.
The Bottom Line
For patients with SMAS: Robotic duodenal derotation with duodenoduodenostomy appears to be a safe and effective option that should be discussed with your surgical team. Confidence level: Moderate (based on one hospital’s experience, but results are promising). For patients with both SMAS and Median Arcuate Ligament Syndrome: This robotic approach can address both conditions in one surgery. Confidence level: Moderate. For surgeons: This technique can be performed safely with robotic assistance and may offer advantages over traditional open surgery. Confidence level: Moderate to High (for experienced robotic surgeons).
This research is most relevant to: Patients diagnosed with SMAS who are considering surgery; patients with both SMAS and MALS; surgeons who perform minimally invasive surgery; and gastroenterologists who refer patients for surgical treatment. This research is less relevant to: Patients with SMAS who are managing symptoms without surgery; people without these rare conditions; and general readers unless they have a personal connection to someone with SMAS.
Based on this study, you can expect: Pain relief within days to weeks after surgery; hospital discharge in about 8-9 days; ability to eat normally and stop using feeding tubes within weeks; weight regain over several weeks to months; and full recovery within 2-3 months. However, individual recovery varies, and some patients may need more time.
Frequently Asked Questions
Is robotic surgery safe for treating superior mesenteric artery syndrome?
Yes, according to a 2026 study of 33 patients, robotic duodenal derotation with duodenoduodenostomy was successful in 97% of cases with zero deaths and only 18% postoperative complications—relatively low for this severely malnourished patient population.
How long does recovery take after robotic SMAS surgery?
Most patients stay in the hospital for about 8-9 days on average. Pain relief typically occurs within days to weeks, ability to eat normally develops within weeks, and full recovery takes 2-3 months. Follow-up in this study ranged from 4 weeks to 2 years.
What percentage of SMAS patients improve after robotic duodenal derotation surgery?
In a 2026 case series of 33 patients, 90.6% experienced significant pain relief, 81.3% stopped needing feeding tubes, and 84.4% regained significant weight—substantially better outcomes than previous surgical techniques.
Can robotic surgery treat both SMAS and Median Arcuate Ligament Syndrome at the same time?
Yes, 19 of 33 patients (58%) in this study had concurrent surgery for both conditions using the robotic approach, with similar positive outcomes, suggesting the technique is versatile for patients with multiple contributing problems.
How does robotic surgery for SMAS compare to traditional open surgery?
This study doesn’t directly compare robotic to open surgery, but results (90.6% pain relief, 84.4% weight regain) appear favorable compared to previous open surgery studies. Robotic surgery typically offers smaller scars, less pain, and faster recovery than traditional open surgery.
Want to Apply This Research?
- If you’ve had this surgery, track daily pain levels (0-10 scale), meals eaten without symptoms, and weekly weight. Log any feeding tube use or supplemental nutrition needed. This data helps you and your doctor monitor recovery progress.
- Start a food diary to identify which foods trigger symptoms and which are well-tolerated. Gradually increase portion sizes as tolerated. Set a weekly weight goal and track progress. Schedule regular check-ins with your surgical team to discuss recovery milestones.
- Use the app to set monthly check-in reminders with your surgeon. Track cumulative weight gain, pain-free days, and nutrition independence. Create a symptom log to identify patterns. Share monthly summaries with your healthcare team to ensure you’re on track for full recovery.
This research describes results from a single surgeon’s experience with 33 patients and should not be considered definitive treatment guidance. Superior mesenteric artery syndrome is a rare, serious condition that requires evaluation and treatment by qualified medical professionals. If you have been diagnosed with SMAS or suspect you may have this condition, consult with a gastroenterologist or surgeon experienced in treating this disorder. Treatment decisions should be made in consultation with your healthcare team based on your individual medical situation, not solely on this research. This article is for educational purposes and does not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.